Dow Research Institute of Biotechnology and Biomedical Sciences (DRIBBS)

Dr. Mohsin Wahid

I am extremely honored to introduce you to the Dow Research Institute of Biotechnology and Biomedical Sciences (DRIBBS). As part of strategic planning 2019-2030, DRIBBS functions as Dow Smart Labs and a centralized facility that facilitates university mission of promoting patient centered research through generation of new knowledge, cutting edge research and innovation. The institute provides a fully equipped research facility for Principal Investigators and Postgraduate students to carry out their projects in DUHS signature programs requiring experimental research. 

In this era of Translational Medicine, it is extremely important to focus the research on bench to bedside and facilitating patient care using advancements like Cellular therapeutics and Gene therapy. Keeping this in view, one of the main themes on which the faculty is involved in research at DRIBBS is:

• Regenerative Medicine, Stem cells & Transplant

To provide a core facility for Basic and Translational research for DUHS signature programs in line with the university mission of promoting patient centered research through generation of new knowledge, cutting edge research and innovation.

Pakistan National Accreditation Council (PNAC)

Drug Regulatory Authority of Pakistan (DRAP)

International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) Guideline for Good Clinical Practice (GCP)

LGC Standards, UK

The Federal Office for Human Research Protection (OHRP)

United States Pharmacopeia (USP)

International Air Transport Association (IATA)

Clinical Trials Network

The Bioinformatics Lab at Dow Research Institute of Biotechnology and Biosciences pioneers data-driven approaches to unravel biological complexities. Our team combines computational analysis with biological insights to tackle challenges in genomics, proteomics, and drug discovery. We drive innovation at the intersection of biology and technology, shaping the future of biomedicine

The BSL III Microbial Lab at Dow Research Institute of Biotechnology and Biosciences TLA conducts cutting-edge research on highly infectious pathogens in a safe and controlled environment. Our expertise in microbiology enables us to study disease mechanisms, develop vaccines, and contribute to global health preparedness against infectious diseases.

The BSL III Virology Lab at Dow Research Institute of Biotechnology and Biosciences TLA is dedicated to studying highly infectious viruses in a secure environment. Our research focuses on understanding viral diseases, developing diagnostics, and advancing treatments and vaccines, contributing to global health and safety against viral threats.

The Cell Culture Lab at Dow Research Institute of Biotechnology and Biosciences specializes in cultivating and studying diverse cell types for scientific research and medical applications. Through meticulous techniques and advanced technologies, we contribute to breakthroughs in biomedicine, drug discovery, and tissue engineering. Our focus is on advancing knowledge and improving human health.

Dow Research Institute of Biotechnology and Biosciences specializes in cell line cryopreservation, ensuring the long-term viability of valuable cell cultures for research and medical applications. Our cutting-edge methods and expertise contribute to advancements in biotechnology, enabling breakthroughs in fields such as medicine, agriculture, and environmental science.

The Chromatography Facility at Dow Research Institute of Biotechnology and Biosciences utilizes high-performance separation techniques to analyze and purify biomolecules. Our expertise in chromatography enables precise identification and isolation of compounds crucial for drug discovery, proteomics, and biotechnology applications, facilitating advancements in science and medicine.

The Fermentation Lab at Dow Research Institute of Biotechnology and Biosciences focuses on harnessing microbial processes for industrial and medical applications. We optimize fermentation conditions to produce valuable compounds like enzymes, pharmaceuticals, and biofuels. Through innovation and collaboration, we drive sustainable solutions for diverse sectors, from healthcare to renewable energy.

The Flow Cytometry Lab at Dow Research Institute of Biotechnology and Biosciences employs cutting-edge technology to analyze and sort cells based on their physical and chemical properties. Our expertise aids in understanding cellular processes, disease mechanisms, and drug responses, driving advancements in biomedicine and biotechnology for improved healthcare outcomes.

The PCR and Gel Electrophoresis Lab at Dow Research Institute of Biotechnology and Biosciences pioneers molecular biology techniques for genetic analysis. Our expertise in PCR amplification and gel electrophoresis enables accurate DNA profiling, gene expression analysis, and genetic engineering, driving advancements in biotechnology, medicine, and agriculture for a sustainable future.

The Protein Analysis Lab at Dow Research Institute of Biotechnology and Biosciences specializes in elucidating the structure, function, and interactions of proteins. Our advanced analytical techniques enable precise characterization, aiding in drug discovery, biomarker identification, and understanding disease mechanisms, fostering innovations in biomedicine and biotechnology for improved human health.

The Spectroscopy Facility at Dow Research Institute of Biotechnology and Biosciences specializes in the analysis of molecules through their interaction with electromagnetic radiation. Our cutting-edge spectroscopic techniques aid in identifying and characterizing compounds, advancing research in fields such as pharmaceuticals, environmental science, and materials science for societal benefit.

The Stem Cell Transplant Biobanking facility at Dow Research Institute of Biotechnology and Biosciences is dedicated to preserving and studying stem cells for therapeutic use. Our state-of-the-art biobanking techniques ensure the integrity and accessibility of stem cell samples, advancing research and medical treatments for various diseases and conditions.

The Stem Cells and Regenerative Medicine Lab (SCRML) at Dow Research Institute of Biotechnology and Biosciences pioneers research in stem cell biology and regenerative therapies. We explore innovative approaches to harness the potential of stem cells for tissue repair and disease treatment, advancing medical science towards improved patient outcomes and healthcare solutions.